Physician profile
Rimon Daoud
NPI 1073724118
$1,421.98
in general payments reported to CMS, 2019-2025
8 companies · $66.67 in 2025
The $66.67 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $245 · 2021: $175 · 2022: $12.51 · 2023: $164 · 2024: $95.98 · 2025: $66.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $671.45 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $270.90 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $201.78 | 2019-2020 | |
| Pfizer INC. | $112.81 | 2019-2020 | |
| Revance Therapeutics, INC. | $66.67 | 2025 | Daxxify |
| Allergan, INC. | $54.60 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $30.70 | 2021-2022 | |
| Glaxosmithkline, LLC. | $13.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rimon Daoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.